₹22.15
₹-0.35 (-1.56%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹11 Cr
P/E
18.29
ROE
4.30%
ROCE
7.56%
About Beryl Drugs Ltd
Beryl Drugs is principally engaged in manufacturing of bulk drugs
Founded
1993
CEO
Sudhir Sethi
Employees
0
HQ
Indore, Madhya Pradesh
About Beryl Drugs Ltd
Beryl Drugs is principally engaged in manufacturing of bulk drugs
Founded:1993
CEO:Sudhir Sethi
Employees:0
HQ:Indore, Madhya Pradesh
Finished Products
1Sales
₹21.53Cr2Scrap
₹0.20CrRaw Materials
1Raw Materials Consumed
₹1.48CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹30
52W Low
₹16
Volume32
Avg VolumeN/A
Beta0.82
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
18.29x
Valuation
P/B Ratio
1.16x
Valuation
EPS
₹1.23
Valuation
Dividend Yield
0.00%
Valuation
ROE
4.30%
Profitability
ROCE
7.56%
Profitability
Revenue by Segment
Contribution & growth by business line
Drug ManufacturingRevenue split N/A
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
0.0%
No geographic split data available
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.25x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
-7.7%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.